Plaintiff
5 cases as plaintiff.
Watchlist
Email-only, free, anonymous. We'll notify you when Jazz Pharmaceuticals files another patent-infringement lawsuit. One-click unsubscribe from any alert.
Jazz sued Wockhardt entities in D.N.J. involving the '106 patent. The case was closed, settled, and Wockhardt was later terminated from the related IPR.
Jazz sued Watson Laboratories in D.N.J. involving the '106 patent. The case was closed and later settled.
Jazz sued Ranbaxy entities in D.N.J. involving the '106 patent. The case was closed and later settled.
Jazz sued Par Pharmaceutical in D.N.J. involving the '106 patent. The case was closed and later settled, with Amneal/Par authorized generic rights from July 1, 2023.
Second D.N.J. suit by Jazz against Roxane Laboratories involving the '106 patent. It was closed.